1
David J Burke, Shaun E Buckley, Sherwood Russ Lehrman, Barbara Horsey O Connor, James Callaway, Christopher P Phillips: Immunoglobulin formulation and method of preparation thereof. Elan Pharmaceuticals, Crowell & Moring, January 8, 2013: US08349321 (32 worldwide citation)

A stable aqueous pharmaceutical formulation comprising a therapeutically effective amount of an antibody, polysorbate 80, a buffer which inhibits polysorbate oxidation is described along with methods of making the preparation. Also described are formulations with high antibody concentrations which m ...


2
David J Burke, Shaun E Buckley, Sherwood Russ Lehrman, Barbara Horsey O Connor, James Callaway, Christopher P Phillips: Method for treating multiple sclerosis and crohns disease. Biogen Idec MA, Yuko Soneoka, Arnold & Porter, August 26, 2014: US08815236

A stable aqueous pharmaceutical formulation comprising a therapeutically effective amount of an antibody, polysorbate 80, a buffer which inhibits polysorbate oxidation is described along with methods of making the preparation. Also described are formulations with high antibody concentrations which m ...


3
David J Burke, Shaun E Buckley, Sherwood Russ Lehrman, Barbara Horsey O Connor, James Callaway, Christopher P Phillips: Immunoglobulin formulation and method of preparation thereof. Biogen Idec Ma, Yuko Soneoka, Arnold & Porter, December 2, 2014: US08900577

A stable aqueous pharmaceutical formulation comprising a therapeutically effective amount of an antibody, polysorbate 80, a buffer which inhibits polysorbate oxidation is described along with methods of making the preparation. Also described are formulations with high antibody concentrations which m ...


4
David J Burke, Shaun E Buckley, Sherwood Russ Lehrman, Barbara Horsey O Connor, James Callaway: Immunoglobulin formulation and method of preparation thereof. Burns Doane Swecker & Mathis L, March 10, 2005: US20050053598-A1

A stable aqueous pharmaceutical formulation comprising a therapeutically effective amount of an antibody, polysorbate 80, a buffer which inhibits polysorbate oxidation is described along with methods of making the preparation. Also described are formulations with high antibody concentrations which m ...


5
Barbara Horsey O Connor, Shaun E Buckley, David Burke: Lyophilized Immunoglobulin Formulations and Methods of Preparation. Elan Pharmaceuticals, Crowell & Moring, August 20, 2009: US20090208492-A1

The present invention relates generally to the field of pharmaceutical formulation of immunoglobulins. Specifically, the present invention relates to stable, lyophilized, high concentration immunoglobulin formulations. This invention is exemplified by a stabilized lyophilized formulation of the reco ...


6
David J BURKE, Shaun E Buckley, Sherwood Russ Lehrman, Barbara Horsey O Connor, James Callaway: Immunoglobulin formulation and method of preparation thereof. Elan Pharmaceuticals, Crowell & Moring, January 28, 2010: US20100021461-A1

A stable aqueous pharmaceutical formulation comprising a therapeutically effective amount of an antibody, polysorbate 80, a buffer which inhibits polysorbate oxidation is described along with methods of making the preparation. Also described are formulations with high antibody concentrations which m ...


7
David J Burke, Shaun E Buckley, Sherwood Russ Lehrman, Barbara Horsey O Connor, James Callaway, Christopher P Phillips: Immunoglobulin Formulation and Method of Preparation Thereof. Elan Pharmaceuticals, December 27, 2012: US20120328614-A1

A stable aqueous pharmaceutical formulation comprising a therapeutically effective amount of an antibody, polysorbate 80, a buffer which inhibits polysorbate oxidation is described along with methods of making the preparation. Also described are formulations with high antibody concentrations which m ...